Holger Schünemann, Elie Akl, Matthias Briel
Status: Laufend Dauer: Apr. 2013 - Juli 2020
Study level systematic reviews on this topic indicate a reduction in venous thromboembolism and provide moderate confidence that a small survival benefit exists. We will perform an individual patient data meta-analysis (IPDMA) to explore the magnitude of the suggested survival benefit and address whether or not specific subgroups and characteristics of cancer patients are more likely to benefit from parenteral anticoagulants.